Do analysts recommend PTHL or AIFF?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pheton 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Firefly Neuroscience 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings and valuation, PTHL or AIFF?

Pheton has higher earnings, but lower revenue than Firefly Neuroscience. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Pheton $305.22K 6.96 -$660K N/A N/A Firefly Neuroscience $1.80M 10.38 -$19.88M -$0.59 N/A

Do analysts prefer HCTI or PTHL?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Healthcare Triangle 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Pheton 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings & valuation, HCTI or PTHL?

Pheton has lower revenue, but higher earnings than Healthcare Triangle. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Healthcare Triangle $25.67M 0.43 -$9.48M -$33.52 N/A Pheton $305.22K 6.96 -$660K N/A N/A

Do analysts recommend ACON or PTHL?

Aclarion currently has a consensus price target of $7.50, suggesting a potential upside of 185.17%. Given Aclarion's stronger consensus rating and higher probable upside, research analysts plainly believe Aclarion is more favorable than Pheton. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aclarion 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Pheton 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation & earnings, ACON or PTHL?

Pheton has higher revenue and earnings than Aclarion. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aclarion $83.77K 90.48 -$7.23M -$7.40 N/A Pheton $305.22K 6.96 -$660K N/A N/A

Is ACON or PTHL more profitable?

Pheton has a net margin of 0.00% compared to Aclarion's net margin of -10,948.81%. Pheton's return on equity of 0.00% beat Aclarion's return on equity. Company Net Margins Return on Equity Return on Assets Aclarion -10,948.81% -59.34% -56.12% Pheton N/A N/A N/A

Do analysts prefer PTHL or ITOC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pheton 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Itonic 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings & valuation, PTHL or ITOC?

Pheton has higher earnings, but lower revenue than Itonic. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Pheton $305.22K 6.96 -$660K N/A N/A Itonic $520K 9.92 -$5.10M N/A N/A

Is PTHL or ITOC more profitable?

Company Net Margins Return on Equity Return on Assets Pheton N/A N/A N/A Itonic N/A N/A N/A

Do analysts recommend VSEE or PTHL?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score VSee Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Pheton 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings & valuation, VSEE or PTHL?

Pheton has lower revenue, but higher earnings than VSee Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio VSee Health $14.46M 0.00 -$14.71M -$0.37 N/A Pheton $305.22K 6.96 -$660K N/A N/A

Is VSEE or PTHL more profitable?

Pheton has a net margin of 0.00% compared to VSee Health's net margin of -92.36%. Pheton's return on equity of 0.00% beat VSee Health's return on equity. Company Net Margins Return on Equity Return on Assets VSee Health -92.36% -11,636.34% -68.62% Pheton N/A N/A N/A

Pheton (PTHL) Competitors

$0.32 +0.00 (+0.75%)

As of 09/23/2026

Compare

PTHL vs. AIFF, HCTI, ACON, ITOC, and VSEE

Should you buy Pheton stock or one of its competitors? Pheton's main competitors and comparable companies include Firefly Neuroscience (AIFF), Healthcare Triangle (HCTI), Aclarion (ACON), Itonic (ITOC), and VSee Health (VSEE). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Pheton compare to Firefly Neuroscience?

Pheton (NASDAQ:PTHL) and Firefly Neuroscience (NASDAQ:AIFF) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, risk, dividends, institutional ownership, profitability, valuation, analyst recommendations and media sentiment.

Pheton has a beta of 5.4, indicating that its stock price is 440% more volatile than the broader market. Comparatively, Firefly Neuroscience has a beta of 0.55, indicating that its stock price is 45% less volatile than the broader market.

Pheton has higher earnings, but lower revenue than Firefly Neuroscience.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pheton	$305.22K	6.96	-$660K	N/A	N/A
Firefly Neuroscience	$1.80M	10.38	-$19.88M	-$0.59	N/A

In the previous week, Firefly Neuroscience had 1 more articles in the media than Pheton. MarketBeat recorded 1 mentions for Firefly Neuroscience and 0 mentions for Pheton. Firefly Neuroscience's average media sentiment score of 0.78 beat Pheton's score of 0.00 indicating that Firefly Neuroscience is being referred to more favorably in the news media.

Company	Overall Sentiment
Pheton	Neutral
Firefly Neuroscience	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pheton	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Firefly Neuroscience	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

5.0% of Firefly Neuroscience shares are held by institutional investors. 6.9% of Firefly Neuroscience shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Pheton has a net margin of 0.00% compared to Firefly Neuroscience's net margin of -506.23%. Pheton's return on equity of 0.00% beat Firefly Neuroscience's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pheton	N/A	N/A	N/A
Firefly Neuroscience	-506.23%	-90.17%	-72.05%

Summary

Firefly Neuroscience beats Pheton on 6 of the 11 factors compared between the two stocks.

How does Pheton compare to Healthcare Triangle?

Healthcare Triangle (NASDAQ:HCTI) and Pheton (NASDAQ:PTHL) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, valuation, profitability, analyst recommendations, earnings and dividends.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Healthcare Triangle	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Pheton	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Healthcare Triangle had 12 more articles in the media than Pheton. MarketBeat recorded 12 mentions for Healthcare Triangle and 0 mentions for Pheton. Healthcare Triangle's average media sentiment score of 0.00 equaled Pheton'saverage media sentiment score.

Company	Overall Sentiment
Healthcare Triangle	Neutral
Pheton	Neutral

Pheton has lower revenue, but higher earnings than Healthcare Triangle.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Healthcare Triangle	$25.67M	0.43	-$9.48M	-$33.52	N/A
Pheton	$305.22K	6.96	-$660K	N/A	N/A

Pheton has a net margin of 0.00% compared to Healthcare Triangle's net margin of -66.85%. Pheton's return on equity of 0.00% beat Healthcare Triangle's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Healthcare Triangle	-66.85%	-125.45%	-36.06%
Pheton	N/A	N/A	N/A

Healthcare Triangle has a beta of 1.09, suggesting that its share price is 9% more volatile than the broader market. Comparatively, Pheton has a beta of 5.4, suggesting that its share price is 440% more volatile than the broader market.

0.3% of Healthcare Triangle shares are owned by institutional investors. 0.1% of Healthcare Triangle shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Pheton beats Healthcare Triangle on 6 of the 10 factors compared between the two stocks.

How does Pheton compare to Aclarion?

Aclarion (NASDAQ:ACON) and Pheton (NASDAQ:PTHL) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, dividends, earnings, risk and media sentiment.

In the previous week, Aclarion had 2 more articles in the media than Pheton. MarketBeat recorded 2 mentions for Aclarion and 0 mentions for Pheton. Aclarion's average media sentiment score of 0.00 equaled Pheton'saverage media sentiment score.

Company	Overall Sentiment
Aclarion	Neutral
Pheton	Neutral

Aclarion has a beta of 1.24, suggesting that its stock price is 24% more volatile than the broader market. Comparatively, Pheton has a beta of 5.4, suggesting that its stock price is 440% more volatile than the broader market.

Aclarion currently has a consensus price target of $7.50, suggesting a potential upside of 185.17%. Given Aclarion's stronger consensus rating and higher probable upside, research analysts plainly believe Aclarion is more favorable than Pheton.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aclarion	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Pheton	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Pheton has higher revenue and earnings than Aclarion.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aclarion	$83.77K	90.48	-$7.23M	-$7.40	N/A
Pheton	$305.22K	6.96	-$660K	N/A	N/A

Pheton has a net margin of 0.00% compared to Aclarion's net margin of -10,948.81%. Pheton's return on equity of 0.00% beat Aclarion's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aclarion	-10,948.81%	-59.34%	-56.12%
Pheton	N/A	N/A	N/A

7.5% of Aclarion shares are owned by institutional investors. 0.0% of Aclarion shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Aclarion beats Pheton on 7 of the 13 factors compared between the two stocks.

How does Pheton compare to Itonic?

Pheton (NASDAQ:PTHL) and Itonic (NASDAQ:ITOC) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings, media sentiment and analyst recommendations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pheton	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Itonic	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Company	Net Margins	Return on Equity	Return on Assets
Pheton	N/A	N/A	N/A
Itonic	N/A	N/A	N/A

In the previous week, Itonic had 12 more articles in the media than Pheton. MarketBeat recorded 12 mentions for Itonic and 0 mentions for Pheton. Pheton's average media sentiment score of 0.00 equaled Itonic'saverage media sentiment score.

Company	Overall Sentiment
Pheton	Neutral
Itonic	Neutral

Pheton has higher earnings, but lower revenue than Itonic.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pheton	$305.22K	6.96	-$660K	N/A	N/A
Itonic	$520K	9.92	-$5.10M	N/A	N/A

Pheton has a beta of 5.4, indicating that its share price is 440% more volatile than the broader market. Comparatively, Itonic has a beta of 2.81, indicating that its share price is 181% more volatile than the broader market.

Summary

Itonic beats Pheton on 3 of the 5 factors compared between the two stocks.

How does Pheton compare to VSee Health?

VSee Health (NASDAQ:VSEE) and Pheton (NASDAQ:PTHL) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, media sentiment, profitability, institutional ownership and valuation.

1.0% of VSee Health shares are owned by institutional investors. 14.9% of VSee Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Pheton has a net margin of 0.00% compared to VSee Health's net margin of -92.36%. Pheton's return on equity of 0.00% beat VSee Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
VSee Health	-92.36%	-11,636.34%	-68.62%
Pheton	N/A	N/A	N/A

In the previous week, VSee Health had 2 more articles in the media than Pheton. MarketBeat recorded 2 mentions for VSee Health and 0 mentions for Pheton. VSee Health's average media sentiment score of 0.00 equaled Pheton'saverage media sentiment score.

Company	Overall Sentiment
VSee Health	Neutral
Pheton	Neutral

Pheton has lower revenue, but higher earnings than VSee Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
VSee Health	$14.46M	0.00	-$14.71M	-$0.37	N/A
Pheton	$305.22K	6.96	-$660K	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
VSee Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Pheton	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Pheton beats VSee Health on 5 of the 9 factors compared between the two stocks.

Get Pheton News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PTHL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PTHL vs. The Competition

Export

Metric	Pheton	Healthcare Technology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$2.13M	$1.75B	$7.26B	$13.10B
Dividend Yield	N/A	3.89%	2.52%	12.57%
P/E Ratio	N/A	20.76	274.98	25.77
Price / Sales	6.96	88.06	679.25	97.61
Price / Cash	N/A	31.72	77.80	52.76
Price / Book	0.34	6.13	10.52	6.34
Net Income	-$660K	-$18.66M	$3.49B	$360.00M
7 Day Performance	6.67%	-1.16%	-1.08%	-0.11%
1 Month Performance	10.70%	1.18%	-3.39%	-3.42%
1 Year Performance	-62.57%	-17.30%	15.08%	5.46%

Pheton Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PTHL Pheton	N/A	$0.32 +0.7%	N/A	-62.8%	$2.13M	$305.22K	N/A	11	Gap Up
AIFF Firefly Neuroscience	0.7062 of 5 stars	$1.28 -0.4%	N/A	-59.6%	$20.01M	$1.80M	N/A	17	Gap Up
HCTI Healthcare Triangle	0.8829 of 5 stars	$0.76 +6.9%	N/A	-99.4%	$11.35M	$25.67M	N/A	80	Trending News Gap Down
ACON Aclarion	2.4549 of 5 stars	$2.59 -2.1%	$7.50 +190.1%	-63.5%	$7.45M	$83.77K	N/A	7	Short Interest Increase
ITOC Itonic	0.836 of 5 stars	$0.31 +4.6%	N/A	N/A	$5.29M	$520K	N/A	N/A	Short Interest Decrease Gap Down High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PTHL) was last updated on 9/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Pheton (PTHL) Competitors

PTHL vs. AIFF, HCTI, ACON, ITOC, and VSEE

How does Pheton compare to Firefly Neuroscience?

Summary

How does Pheton compare to Healthcare Triangle?

Summary

How does Pheton compare to Aclarion?

Summary

How does Pheton compare to Itonic?

Summary

How does Pheton compare to VSee Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PTHL vs. The Competition

Pheton Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Pheton (PTHL) Competitors

PTHL vs. AIFF, HCTI, ACON, ITOC, and VSEE

How does Pheton compare to Firefly Neuroscience?

Which has more risk and volatility, PTHL or AIFF?

Which has better earnings and valuation, PTHL or AIFF?

Does the media refer more to PTHL or AIFF?

Do analysts recommend PTHL or AIFF?

Do insiders & institutionals hold more shares of PTHL or AIFF?

Is PTHL or AIFF more profitable?

Summary

How does Pheton compare to Healthcare Triangle?

Do analysts prefer HCTI or PTHL?

Does the media refer more to HCTI or PTHL?

Which has stronger earnings & valuation, HCTI or PTHL?

Is HCTI or PTHL more profitable?

Which has more volatility & risk, HCTI or PTHL?

Do insiders & institutionals have more ownership in HCTI or PTHL?

Summary

How does Pheton compare to Aclarion?

Does the media favor ACON or PTHL?

Which has more risk and volatility, ACON or PTHL?

Do analysts recommend ACON or PTHL?

Which has preferable valuation & earnings, ACON or PTHL?

Is ACON or PTHL more profitable?

Do institutionals & insiders have more ownership in ACON or PTHL?

Summary

How does Pheton compare to Itonic?

Do analysts prefer PTHL or ITOC?

Is PTHL or ITOC more profitable?

Does the media refer more to PTHL or ITOC?

Which has stronger earnings & valuation, PTHL or ITOC?

Which has more risk and volatility, PTHL or ITOC?

Summary

How does Pheton compare to VSee Health?

Do insiders and institutionals believe in VSEE or PTHL?

Is VSEE or PTHL more profitable?

Does the media prefer VSEE or PTHL?

Which has preferable earnings & valuation, VSEE or PTHL?

Do analysts recommend VSEE or PTHL?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PTHL vs. The Competition

Pheton Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools